Deficiency of Alpha-1-Antitrypsin
We recommend
Augmentation Therapy of Bronchiectasis Due to AATD – Case Report
Alpha-1-antitrypsin deficiency (AATD) is a rare cause of bronchiectasis unrelated to cystic fibrosis. The role of augmentation therapy with alpha-1-antitrypsin (AAT) in patients with AATD with bronchiectasis without pulmonary emphysema is still unclear. A case report from authors in Heidelberg presents a patient with bronchiectasis based on AATD, where augmentation therapy reduced the number of exacerbations and improved clinical condition.
Repeated Episodes of Respiratory Failure Due to Undiagnosed AAT Deficiency – Case Report
The case report from authors in Naples shows that alpha-1-antitrypsin deficiency (AATD) should be…
Interactive Case Study: AATD – Alpha-1-Antitrypsin Deficiency
We present a case study of a man who was 41 years old at the time of his first contact with a…
No content is currently available on this topic.
Subscribe
Conferences news
3 records
Go to records
Go to records
Go to records
Go to records
Most read on this topic
- Augmentation Therapy of Bronchiectasis Due to AATD – Case Report
- Interactive Case Study: AATD – Alpha-1-Antitrypsin Deficiency
- Repeated Episodes of Respiratory Failure Due to Undiagnosed AAT Deficiency – Case Report
Related topic
Interesting links